Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMoving from 2.5mg to 5mg Mounjaro tends to bring a fresh wave of nausea, stomach discomfort or loose stools for a week or two — the same pattern many people noticed when they first started. This happens because 5mg is the first dose where tirzepatide begins doing meaningful therapeutic work, and your digestive system needs time to adjust. As a prescription-only medicine, tirzepatide must be prescribed following a clinical assessment; your prescriber decides whether and when increasing your dose is appropriate based on how you've responded so far. The NHS patient information for tirzepatide on NHS.uk describes this GI settling pattern clearly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Patients often tell our prescribers they assumed stronger side effects after increasing to 5mg meant the medicine wasn't agreeing with them. That's understandable, but it isn't quite right. The 2.5mg starting pen exists largely to let your gut settle in gradually, it's a tolerability phase rather than a therapeutic one. When you step up to 5mg, tirzepatide's dual GIP and GLP-1 receptor activity becomes more pronounced, gastric emptying slows a little more, and appetite signals dampen more noticeably. All of that is the medicine working. The gastrointestinal response that sometimes accompanies it is a consequence of that stronger effect, not a sign of failure or allergy. Most people find it peaks around days three to seven of the new pen and then gradually softens. That said, gently letting go of the idea that side effects equal a problem doesn't mean ignoring them, it means knowing which ones to ride out and which ones require a call.
If you want a fuller picture of what the 2.5mg phase felt like by comparison, the side effects at 2.5mg page covers that earlier window in detail. If you're currently navigating going from 2.5 to 5 Mounjaro, that page walks through what the step-up process typically looks like and what to expect along the way.
Nausea is the most frequently reported symptom at this step. It tends to be worse in the hour or two after eating rather than constantly present, and eating smaller portions more slowly helps considerably. Loose stools or diarrhoea are the next most common; constipation is less typical at this stage but does occur. Indigestion, reflux and burping are reported by a meaningful minority, usually settling within two weeks. Headache, mild fatigue and dizziness can accompany the GI symptoms, often as a downstream effect of reduced appetite or slightly lower caloric intake, staying hydrated and keeping protein intake reasonable matters here. Injection-site redness or itching is possible; rotating between the abdomen, thigh and upper arm helps reduce that. The Mounjaro SmPC on the eMC lists all reported frequencies by system class for anyone who wants the clinical detail. The practical summary: most of what you experience at 5mg will be a louder version of what you noticed at 2.5mg, and most of it will quieten down.
For a closer look at what the 5mg pen brings specifically, our page on 2.5mg to 5mg Mounjaro side effects covers how symptoms shift as you move between those two doses, and Mounjaro 5mg side effects covers the dose in full.
Some symptoms should not be waited out. Seek urgent medical attention for severe stomach pain that radiates to your back, with or without vomiting, this can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Signs of a significant allergic reaction (facial swelling, difficulty breathing, a widespread rash) also need emergency assessment, not a GP appointment. If persistent vomiting or diarrhoea is leaving you unable to keep fluids down for more than a day, contact a healthcare professional; dehydration can affect the kidneys and it escalates faster than people expect. Gallbladder symptoms (sharp pain in the upper right abdomen, particularly after eating) are another category that warrants prompt review rather than monitoring at home. For anything that concerns you but doesn't feel urgent, our prescribers are available to discuss it; you can reach the team via the contact page. And if you experience something you believe is a side effect of your treatment, you can log it directly with the MHRA at yellowcard.mhra.gov.uk, that reporting genuinely contributes to ongoing medicine safety monitoring.
Small, frequent meals work better than three full ones during the adjustment window. The stomach empties more slowly on 5mg, so a large meal arriving on top of that can tip nausea from mild to miserable. Cold or room-temperature food often sits better than hot meals for the first few days. Avoiding very fatty or highly spiced food during the first fortnight is a practical measure, not a permanent restriction. Alcohol amplifies reflux and nausea on GLP-1 medicines and is worth limiting while the step-up settles. Keeping a water bottle nearby and sipping through the day rather than drinking large amounts in one go reduces both nausea and the dehydration risk if your gut is unsettled. These are general supportive measures, your specific situation, any other medicines you take and your medical history all shape what's right for you, and that's a conversation for your prescriber rather than a page like this one. If you're already thinking ahead to your next increase, the page on Mounjaro 7.5 side effects gives a useful sense of what that stage tends to involve. The full picture of how Mounjaro works across all its doses is on the Mounjaro overview page, and the free consultation is where our prescribers discuss your dose, your response and what to expect at each stage.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.